by sherry | Dec 20, 2021 | Press Release
“The joint study has confirmed that personalized PBM dosing is key to MDD treatment.” Irvine, Calif.—Niraxx Light Therapeutics, a leader in wearable neurotechnology, today announced recent study findings supporting the company’s personalized PBM...
